Literature DB >> 2824756

Prolonged depolarization increases the pharmacological effect of dihydropyridines and their binding affinity for calcium channels of vascular smooth muscle.

N Morel1, T Godfraind.   

Abstract

Experiments were performed on isolated rat mesenteric arteries with the calcium-antagonistic dihydropyridine derivative PN 200-110 in order to examine how its time-dependent effect on K+-evoked contraction might be related to voltage sensitive binding. (+)-PN 200-110 is a potent blocker of the K+-contraction in mesenteric artery. Inhibition of the K+-contraction was time-dependent and dose-effect curves were shifted to the left with the duration of depolarization. The (-)-isomer of PN 200-110 was less potent than the (+)-isomer but its action was also time-dependent. (+)-[3H]PN 200-110 binding has been determined in arteries bathed in physiological or high K+-solutions. Nonspecific binding measured in the presence of 10(-6) M nifedipine was not different in polarized and in depolarized arteries but specific binding was increased markedly after 30 min of depolarization. Specific binding data were well fitted by one hyperbolic curve describing a one-to-one binding to a single class of sites. Maximum binding capacity was unchanged whereas apparent dissociation constant was significantly lower in depolarized arteries. Depolarization also shifted to the left displacement curves of (+)-[3H]PN 200-110 by (+)- and (-)-PN 200-110. These results indicate that time-dependent effect of dihydropyridines in vascular smooth muscle is related to increased affinity of depolarized arteries for those drugs, suggesting that calcium channels in vascular smooth muscle are modulated by membrane potential in a way similar to that reported for cardiac muscle.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2824756

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  15 in total

1.  Dihydropyridine enantiomers block recombinant L-type Ca2+ channels by two different mechanisms.

Authors:  R Handrock; R Rao-Schymanski; N Klugbauer; F Hofmann; S Herzig
Journal:  J Physiol       Date:  1999-11-15       Impact factor: 5.182

Review 2.  Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis.

Authors:  Théophile Godfraind
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

3.  Regulation of the L-type calcium channel alpha-1 subunit by chronic depolarization in the neuron-like PC12 and aortic smooth muscle A7r5 cell lines.

Authors:  O Feron; T Godfraind
Journal:  Pflugers Arch       Date:  1995-07       Impact factor: 3.657

4.  Barnidipine block of L-type Ca(2+) channel currents in rat ventricular cardiomyocytes.

Authors:  J W Wegener; H Meyrer; J Rupp; H Nawrath
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

5.  Pharmacological properties of voltage-dependent calcium channels in functional microvessels isolated from rat brain.

Authors:  N Morel; T Godfraind
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

6.  Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle.

Authors:  S Salomone; T Godfraind
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

7.  (+)-S-12967 and (-)-S-12968: 1,4-dihydropyridine stereoisomers with calcium channel agonistic and antagonistic properties in rat resistance arteries.

Authors:  D Prieto; M J Mulvany; N C Nyborg
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

Review 8.  Cardioselectivity of calcium antagonists.

Authors:  T Godfraind
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

9.  Selective modulation by membrane potential of the interaction of some calcium entry blockers with calcium channels in rat mesenteric artery.

Authors:  N Morel; T Godfraind
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

10.  Characterization in rat aorta of the binding sites responsible for blockade of noradrenaline-evoked calcium entry by nisoldipine.

Authors:  N Morel; T Godfraind
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.